SAN DIEGO, CA–(Marketwired – August 15, 2013) – NuVasive Inc, a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to announce the expansion and relocation of the Company’s UK office.
The office relocation will enable NuVasive to better execute its market share taking strategy across Northern Europe. The modern two-story, 7,500-square-foot facility adds office space, increases warehousing capabilities, and provides dedicated space for staff training and surgeon events.
Russell Powers, NuVasive Executive Vice President of International, said, “The larger facility in London will allow NuVasive to increase our capabilities in key areas that align well with our international growth plans. We are adding significant sales talent and operational support to increase the penetration of our comprehensive portfolio of procedurally-integrated spine products not just in the UK, but across all of Europe.”
Alex Lukianov, NuVasive Chairman and Chief Executive Officer, said, “Over the past few years, NuVasive has strategically expanded into international markets to proliferate minimally invasive spine surgery globally. Through our unique culture of Absolute Responsiveness to surgeon and hospital customers, we intend to improve more patient outcomes in the UK and around the world.”
The original UK office opened in 2008, and was the Company’s first office to be located abroad. With eight international offices located in Europe, Australia, and Asia, NuVasive currently has a presence in over 25 countries.